Joan Gavalda

Summary

Publications

  1. doi request reprint Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients
    J Gavalda
    Department of Infectious Diseases, Universitat Autonoma de Barcelona, Hospital Universitari Vall d Hebron, Barcelona, Spain
    Pediatr Transplant 17:403-6. 2013
  2. doi request reprint Influenza A H1N1/2009 infection in pediatric solid organ transplant recipients
    J Gavalda
    Department of Infectious Diseases, Hospital Universitari Vall d Hebron, Barcelona, Spain Spanish Network for Research in Infectious Diseases REIPI, Spain
    Transpl Infect Dis 14:584-8. 2012
  3. doi request reprint [Invasive fungal infection in solid organ transplant]
    Joan Gavalda
    Servicio de Enfermedades Infecciosas, Hospital Universitari Vall d Hebron, Barcelona, Espana
    Enferm Infecc Microbiol Clin 30:645-53. 2012
  4. doi request reprint Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation
    Victor Monforte
    Respiratory Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    J Heart Lung Transplant 29:523-30. 2010
  5. ncbi request reprint Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis
    Maria Teresa Martin
    Infectious Diseases Research Laboratory, Infectious Diseases Division, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    J Antimicrob Chemother 52:1032-4. 2003
  6. ncbi request reprint Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients
    Victor Monforte
    Department of Pneumology, Hospital General Vall d Hebron, Universitat Autonoma de Barcelona, Spain
    Transplantation 75:1571-4. 2003
  7. pmc Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis
    Joan Gavalda
    Infectious Diseases Research Laboratory, Infectious Diseases Division, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    Antimicrob Agents Chemother 49:3028-30. 2005
  8. doi request reprint Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study
    Oscar Len
    Infectious Diseases Department, Hospital Vall d Hebron, Barcelona, Spain
    Transpl Int 25:1275-81. 2012
  9. doi request reprint Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety
    Victor Monforte
    Department of Pulmonology, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    J Heart Lung Transplant 28:170-5. 2009
  10. ncbi request reprint Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone
    Joan Gavalda
    Hospital Universitari Vall d Hebron, Institut d Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain
    Ann Intern Med 146:574-9. 2007

Collaborators

Detail Information

Publications24

  1. doi request reprint Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients
    J Gavalda
    Department of Infectious Diseases, Universitat Autonoma de Barcelona, Hospital Universitari Vall d Hebron, Barcelona, Spain
    Pediatr Transplant 17:403-6. 2013
    ..Seroconversion was demonstrated in 15 of 17 (88.2%) vaccinated children. There were no rejection episodes or major adverse events. The MF59(®) -adjuvanted pandemic H1N1/2009 vaccine was safe and elicited an adequate response...
  2. doi request reprint Influenza A H1N1/2009 infection in pediatric solid organ transplant recipients
    J Gavalda
    Department of Infectious Diseases, Hospital Universitari Vall d Hebron, Barcelona, Spain Spanish Network for Research in Infectious Diseases REIPI, Spain
    Transpl Infect Dis 14:584-8. 2012
    ....
  3. doi request reprint [Invasive fungal infection in solid organ transplant]
    Joan Gavalda
    Servicio de Enfermedades Infecciosas, Hospital Universitari Vall d Hebron, Barcelona, Espana
    Enferm Infecc Microbiol Clin 30:645-53. 2012
    ..The current document has focused mainly on Candidaspp. and Aspergillusspp., with a special mention to the rest of yeasts and moulds that are common in SOT...
  4. doi request reprint Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation
    Victor Monforte
    Respiratory Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    J Heart Lung Transplant 29:523-30. 2010
    ..Nebulized liposomal amphotericin B (n-LAB) is another option; however, no clinical data are available on the results of n-LAB for this purpose...
  5. ncbi request reprint Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis
    Maria Teresa Martin
    Infectious Diseases Research Laboratory, Infectious Diseases Division, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    J Antimicrob Chemother 52:1032-4. 2003
    ..Differences in efficacy between deoxycholate amphotericin B (d-AmB) and escalating doses of liposomal amphotericin B (L-AmB) were evaluated in a model of invasive pulmonary aspergillosis in persistently steroid-immunosuppressed rats...
  6. ncbi request reprint Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients
    Victor Monforte
    Department of Pneumology, Hospital General Vall d Hebron, Universitat Autonoma de Barcelona, Spain
    Transplantation 75:1571-4. 2003
    ..The aim of this study was to ascertain the concentrations and distribution of nAB in the respiratory tract of patients receiving lung transplantations...
  7. pmc Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis
    Joan Gavalda
    Infectious Diseases Research Laboratory, Infectious Diseases Division, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    Antimicrob Agents Chemother 49:3028-30. 2005
    ....
  8. doi request reprint Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study
    Oscar Len
    Infectious Diseases Department, Hospital Vall d Hebron, Barcelona, Spain
    Transpl Int 25:1275-81. 2012
    ..95; 95%CI 1.1-7.9; P = 0.031). There were no deaths related to CDAD. In summary, the incidence of CDAD in SOT was low, most cases were diagnosed soon after transplantation and the prognosis was good...
  9. doi request reprint Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety
    Victor Monforte
    Department of Pulmonology, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    J Heart Lung Transplant 28:170-5. 2009
    ..The aim of this study was to measure post-inhalation amphotericin B concentration in the respiratory tract and serum of lung transplant patients and assess the effects of n-LAB on respiratory function...
  10. ncbi request reprint Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone
    Joan Gavalda
    Hospital Universitari Vall d Hebron, Institut d Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain
    Ann Intern Med 146:574-9. 2007
    ..High-level aminoglycoside resistance (HLAR) that precludes bactericidal synergism with penicillins or glycopeptides and nephrotoxicity related to aminoglycoside treatment are major problems in treating Enterococcus faecalis endocarditis...
  11. doi request reprint [Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update]
    Jesus Fortun
    Servicio de Enfermedades Infecciosas, Hospital Universitario Ramon y Cajal, Madrid, Spain
    Enferm Infecc Microbiol Clin 29:435-54. 2011
    ..Specific recommendations on the prevention of fungal infections in these patients are included...
  12. doi request reprint Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection
    Nuria Fernandez-Hidalgo
    Infectious Diseases Department, Hospital Universitari Vall d Hebron, Barcelona, Spain
    J Antimicrob Chemother 65:525-30. 2010
    ..The effectiveness of linezolid, vancomycin, ciprofloxacin and gentamicin for treating experimental Staphylococcus aureus catheter-related infection by the antibiotic-lock technique was assessed...
  13. doi request reprint Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients
    Jesus Fortun
    Department of Infectious Diseases, Ramon y Cajal Hospital, Madrid, Spain
    Transplantation 87:424-35. 2009
    ..The aim of this prospective, multicenter, noncomparative, open-label trial was to evaluate the prophylactic use of caspofungin in adult liver transplant recipients at high risk of developing invasive fungal infections (IFI)...
  14. ncbi request reprint Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection
    Yolanda Meije
    Infectious Diseases Research Laboratory, Infectious Diseases Department, Hospital Universitari Vall d Hebron, Barcelona, Spain
    J Infect 68:548-52. 2014
    ..The effectiveness of daptomycin versus vancomycin for treating experimental methicillin-susceptible (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) catheter-related infection by antibiotic-lock technique was assessed...
  15. ncbi request reprint [Infection in lung transplantation]
    Joan Gavalda
    Servicio de Enfermedades Infecciosas, Hospital Vall d Hebron, Barcelona, Spain
    Enferm Infecc Microbiol Clin 25:639-49; quiz 650. 2007
    ..in contrast to others in which infection by Candida spp. is most common. The incidence of invasive aspergillosis is about 4%...
  16. doi request reprint Safety of liver transplantation with Chagas disease-seropositive donors for seronegative recipients
    Fernando Salvador
    Department of Infectious Diseases, Vall d Hebron University Hospital, Barcelona, Spain
    Liver Transpl 17:1304-8. 2011
    ..We also provide a review of the literature and emphasize donor screening and preventive measures...
  17. ncbi request reprint [Prevention of cytomegalovirus disease in lung transplantation]
    Joan Gavalda
    Servicio de Enfermedades Infecciosas, Hospital Universitari Vall d Hebron, Barcelona, Espana
    Enferm Infecc Microbiol Clin 29:46-51. 2011
    ..In D+/R- recipients, this period can be prolonged to 12 months if there are difficulties in monitoring at 6 months posttransplantation. The future of prevention will probably depend on immunoguided strategies...
  18. ncbi request reprint Liver biopsy-related infection in liver transplant recipients: A current matter of concern?
    Cristina López Sánchez
    Departments of Infectious Diseases, Autonomous University of Barcelona, Barcelona, Spain
    Liver Transpl 20:552-6. 2014
    ....
  19. ncbi request reprint Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: A cohort study
    Cristina Pérez-Cameo
    Liver Unit, Department of Internal Medicine, Vall d Hebron Hospital, Barcelona, Spain
    Liver Transpl 20:856-63. 2014
    ..08), being an LT recipient (OR = 3.47), a known etiology (OR = 2.08), and the presence of hepatocellular carcinoma (OR = 3.73). Liver Transpl 20:856-863, 2014. © 2014 AASLD. ..
  20. ncbi request reprint Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Vicenc Falco
    Infectious Disease Department, Hospitals Vall d Hebron, Universitat Autonoma de Barcelona, P degrees Vall d Hebron 119 129, 08035 Barcelona, Spain
    J Antimicrob Chemother 54:481-8. 2004
    ..12-1 mg/L treated empirically during the first 48 h with beta-lactam antibiotics...
  21. doi request reprint Full face transplant: the first case report
    Juan P Barret
    Department of Plastic Surgery and Burns, University Hospital Vall d Hebron, Universitat Autonoma de Barcelona, Spain
    Ann Surg 254:252-6. 2011
    ..Since 2005, 11 human face transplants have been performed. In each, varying amounts of tissue have been transplanted. Herein we report a "full" face transplant including all intact aesthetic and functional units...
  22. doi request reprint Infection prevention in solid organ transplantation
    Joan Gavalda
    Infectious Diseases Senior Consultant, Infectious Diseases Department, Hospital Universitari Vall d Hebron, Barcelona, Spain
    Enferm Infecc Microbiol Clin 30:27-33. 2012
    ....
  23. doi request reprint Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control study
    Núria Fernàndez-Sabé
    Infectious Disease Service, Intitut d Investigació Biomèdica de Bellvitge Hospital Universitari de Bellvitge, Barcelona, Spain
    Clin Infect Dis 49:1153-9. 2009
    ..Solid-organ transplant (SOT) recipients are classically considered to be at increased risk for listeriosis. However, risk factors for this infection have not been assessed...
  24. ncbi request reprint Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides
    Joan Gavalda
    Infectious Diseases Research Laboratory, Infectious Diseases Division, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Avda Vall d Hebron, 119 129, 08035 Barcelona, Spain
    J Antimicrob Chemother 52:514-7. 2003
    ..It also determines whether adding ceftriaxone to ampicillin and gentamicin increases the effectiveness against experimental enterococcal endocarditis resulting from E. faecalis...